An increasing number of studies have reported that FTO-mediated epigenetic modifications play an important role in the regulation of immune responses and metabolic diseases, such as acute myeloid leukemia, heart failure, and type 2 diabetes (45–47). This evidence concerns the gene FTO and Other metabolic disease.